载脂蛋白L1高危基因型与撒哈拉以南非洲人群的白蛋白尿
这项在四个非洲国家开展的横断面人群研究纳入10769名 largely 40-60岁参与者,发现APOL1 G1和G2等位基因频率在西非和南非内部及之间不同,东非几乎缺失;APOL1风险变异与白蛋白尿相关,但与eGFR<60 ml/min per 1.73 m2无关。
要点
- APOL1 G1/G1基因型与白蛋白尿的关联强于G2/G2或G1/G2。
- APOL1风险变异与eGFR<60 ml/min per 1.73 m2无关联。
- G1和G2等位基因频率在西非和南非之间及内部存在差异,东非几乎缺失。
核心结论
- APOL1 G1和G2等位基因及高危基因型频率在西非和南非之间及内部存在差异,东非几乎缺失。
- APOL1风险变异与白蛋白尿相关,但与eGFR<60 ml/min per 1.73 m2无关。
- 纯合G1和G2基因型对白蛋白尿可能存在不同效应,需进一步研究。
研究设计与样本
- 横断面人群研究,在四个非洲国家纳入10769名参与者,大多年龄40-60岁。
- 收集社会人口学和健康信息、人体测量数据及血液和尿液肾脏病生物标志物检测。
- APOL1风险等位基因从H3Africa基因分型芯片推断,并分析基因型与肾脏病的关联。
主要发现
- G1等位基因高频率见于南非和西非(约7%-13%)。
- G2等位基因频率在南非最高(15%-24%),其次为西非(9%-12%)。
- APOL1风险变异与白蛋白尿的关联在隐性模型(比值比1.63;95%置信区间1.25至2.12)和加性模型(比值比1.39;95%置信区间1.09至1.76)中显著。
- APOL1 G1/G1基因型与G0/G0相比的关联(比值比3.87;95%置信区间2.16至6.93)强于G2/G2(比值比1.65;95%置信区间1.09至2.51)或G1/G2(比值比1.24;95%置信区间0.83至1.87)。
- 未观察到APOL1风险变异与eGFR<60 ml/min per 1.73 m2的关联。
关键数值与推荐
- 肾脏病定义为eGFR<60 ml/min per 1.73 m2、白蛋白尿或包含eGFR<60 ml/min per 1.73 m2和/或白蛋白尿的复合终点。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Recessive inheritance of African-specific APOL1 kidney risk variants is associated with higher risk of nondiabetic kidney disease, progression to kidney failure, and early-onset albuminuria that precedes eGFR decline. The effect of APOL1 risk variants on kidney disease in continental Africans is understudied. Objectives of this study were to determine APOL1 risk allele prevalence and associations between APOL1 genotypes and kidney disease in West, East, and South Africa. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This cross-sectional population-based study in four African countries included 10,769 participants largely aged 40-60 years with sociodemographic and health information, anthropometry data, and blood and urine tests for biomarkers of kidney disease. APOL1 risk alleles were imputed from the H3Africa genotyping array, APOL1 risk allele and genotype frequencies were determined, and genetic associations were assessed for kidney disease. Kidney disease was defined as the presence of eGFR <60 ml/min per 1.73 m2, albuminuria, or a composite end point including eGFR <60 ml/min per 1.73 m2 and/or albuminuria. RESULTS: High G1 allele frequencies occurred in South and West Africa (approximately 7%-13%). G2 allele frequencies were highest in South Africa (15%-24%), followed by West Africa (9%-12%). Associations between APOL1 risk variants and albuminuria were significant for recessive (odds ratio, 1.63; 95% confidence interval, 1.25 to 2.12) and additive (odds ratio, 1.39; 95% confidence interval, 1.09 to 1.76) models. Associations were stronger for APOL1 G1/G1 genotypes versus G0/G0 (odds ratio, 3.87; 95% confidence interval, 2.16 to 6.93) compared with either G2/G2 (odds ratio, 1.65; 95% confidence interval, 1.09 to 2.51) or G1/G2 (odds ratio, 1.24; 95% confidence interval, 0.83 to 1.87). No association between APOL1 risk variants and eGFR <60 ml/min per 1.73 m2 was observed. CONCLUSIONS: APOL1 G1 and G2 alleles and high-risk genotype frequencies differed between and within West and South Africa and were almost absent from East Africa. APOL1 risk variants were associated with albuminuria but not eGFR <60 ml/min per 1.73 m2. There may be differential effects of homozygous G1 and G2 genotypes on albuminuria that require further investigation. PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2022_05_16_CJN14321121.mp3.
引用
- Brandenburg JT, Govender MA, Winkler CA, et al. Apolipoprotein L1 High-Risk Genotypes and Albuminuria in Sub-Saharan African Populations. Clin J Am Soc Nephrol. 2022. PMID: 35577564. doi:10.2215/CJN.14321121
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。